During the congress, ZAS Corporation Ltd. showcased its specialized respiratory and critical care therapeutic portfolio, reflecting the company’s continued commitment to advancing healthcare solutions for respiratory and chest-related diseases. The event provided an excellent platform to share scientific knowledge, exchange clinical insights, and discuss the latest developments in pulmonary healthcare and patient management.

Throughout the program, representatives from ZAS Corporation Ltd. actively engaged with healthcare professionals and industry experts, fostering meaningful discussions on innovative treatment approaches and emerging trends in respiratory medicine. These interactions reinforced the company’s dedication to supporting the medical community with high-quality, patient-centric healthcare solutions.

Participation in the AGM & International Chest Congress 2026 further demonstrates ZAS Corporation Ltd.’s ongoing commitment to contributing to medical excellence, continuous scientific advancement, and improved patient outcomes in respiratory care.

ZAS Corporation Ltd. remains steadfast in its mission to collaborate with healthcare professionals and organizations in shaping a healthier future through innovation, quality, and excellence.

The event brought together key stakeholders and team members in a dynamic setting filled with energy, forward-thinking ideas, and a unified vision for the future. The presence of the global leadership team added depth to the discussions, fostering alignment on strategic priorities and reinforcing a shared commitment to advancing healthcare solutions.

The meeting served as a valuable opportunity to reflect on the achievements of the past year, recognize the dedication and hard work that fueled each success, and set the stage for even greater accomplishments ahead. It also highlighted the strength of collaboration between ZAS Corporation Ltd. and OMRON Healthcare Bangladesh in driving impactful initiatives within the healthcare sector. As the teams look forward to FY’26, the focus remains on pushing boundaries, embracing innovation, and delivering meaningful contributions that improve lives. With a strong foundation and a shared sense of purpose, both organizations are well-positioned to achieve new heights in the coming year.

Participants took to the track with energy and purpose, symbolizing unity in the fight against heart-related diseases. The event highlighted the importance of regular physical activity, preventive care, and community engagement in building a healthier society.

ZAS Corporation Ltd. proudly joined the initiative as a Co-Sponsor, reinforcing its commitment to supporting impactful health-focused programs. Through its involvement, the organization aimed to contribute to raising awareness and encouraging positive lifestyle changes among the public. The success of “Run for Healthy Heart 2026” reflects a growing awareness and collective responsibility toward health and wellness. As participants crossed the finish line, they carried forward a strong message: every step counts in shaping a stronger, healthier future for all.

ZAS Industries proudly participated in the 18th International Surgical Congress, organized by the Society of Surgeons of Bangladesh (SOSB), reaffirming its commitment to supporting surgical excellence and advancing healthcare standards in the country.

During the congress, the ZAS team actively engaged with distinguished surgeons and healthcare professionals, exchanging valuable insights on the latest surgical advancements, innovations, and patient care practices. These meaningful interactions highlighted ZAS Industries’ dedication to understanding the evolving needs of the surgical community.

The participation further reinforced ZAS Industries’ promise to deliver innovative, high-quality healthcare solutions that empower surgical teams and enhance patient outcomes. ZAS remains dedicated to partnering with the surgical fraternity and the broader medical community to drive clinical excellence and improve health outcomes across Bangladesh.

ZAS Corporation proudly participated in the 17th Annual Scientific Conference 2025, organized by the Bangladesh Rheumatology Society, highlighting its ongoing commitment to advancing rheumatology care in Bangladesh.

During the conference, ZAS showcased its dedicated Rheumatology portfolio, developed to effectively manage rheumatic diseases and significantly improve patients’ quality of life. The event served as an important platform for interaction, where the ZAS team engaged with leading rheumatologists and healthcare experts, exchanging valuable insights on the latest treatment approaches and management strategies for arthritis and autoimmune conditions.

These professional interactions reflect ZAS Corporation’s continuous effort to bring advanced, patient-centered therapeutic solutions to the forefront of healthcare. ZAS remains firmly committed to supporting the Bangladesh Rheumatology Society and the wider medical community in ensuring improved care and better outcomes for patients living with rheumatic disorders.

ZAS Corporation Ltd. proudly participated in the 1st International Meeting on Regional Anaesthesia Bangladesh 2025, organized by the Bangladesh Society of Regional Anesthesia (BASRA). The event served as a platform for leading experts and practitioners to exchange knowledge and insights on advanced regional anesthesia practices.

During the meeting, the ZAS team actively engaged in meaningful discussions, exploring the latest techniques and innovations in anesthesia care. These interactions reinforced ZAS Corporation Ltd.’s commitment to supporting the medical community with high-quality, patient-focused solutions. ZAS remains dedicated to advancing clinical excellence and improving patient outcomes in anesthesia care across Bangladesh.

ZAS Corporation Ltd. proudly participated in the 8th National Scientific Conference 2025, organized by the Bangladesh Paediatric Pulmonology Forum, reaffirming its commitment to advancing child-focused respiratory healthcare.

At the conference, ZAS showcased its specialized Paediatric Pulmonology treatment portfolio, designed to support effective respiratory care for children and enhance their overall quality of life. The event provided a valuable platform for meaningful engagement with leading paediatric pulmonologists and healthcare professionals, where the ZAS team exchanged insights on the latest approaches to managing childhood respiratory and pulmonary conditions.

These interactions further strengthened ZAS Corporation Ltd.’s dedication to delivering innovative, evidence-based therapeutic solutions tailored to children’s needs. ZAS remains steadfast in its support of the Bangladesh Paediatric Pulmonology Forum and the wider medical community, working collaboratively to ensure improved respiratory care and healthier futures for children across Bangladesh.

ZAS Corporation proudly participated in the 11th International Neuro Conference 2025, reaffirming its commitment to advancing neuroscience and improving patient access to quality neurological care.

During the conference, the ZAS team engaged with leading neurologists and neurosurgeons, exchanging practical insights and discussing the latest breakthroughs in brain health and treatment management. The event provided a valuable platform for professional dialogue on emerging trends and innovations in neurological therapies.

These meaningful interactions reinforced ZAS Corporation’s dedication to making high-quality neurological treatments accessible to patients who need them most. ZAS remains committed to supporting the medical community and contributing to improved clinical outcomes in neuroscience across the country.

ZAS Corporation proudly participated in MOSB Congress 2025, reaffirming its commitment to advancing oncology care in Bangladesh through Celltrion’s biosimilar portfolio.

During the event, the ZAS oncology team engaged with distinguished medical professionals, exchanging knowledge and exploring the latest innovations in cancer treatment. These meaningful discussions reinforced the shared vision of making advanced therapies more accessible to patients in need.

ZAS Corporation remains dedicated to improving patient outcomes and collaborating with the medical community to shape a stronger, more progressive future for oncology care in Bangladesh.

ZAS Corporation was honored to participate in the EHA–HSB Hematology Tutorial 2025, underscoring its commitment to advancing hematology care in Bangladesh.

The event served as a valuable platform for engaging with leading medical professionals and exchanging insights on the latest developments in hematology. Through these meaningful discussions, the ZAS team reinforced a shared vision of improving access to advanced therapies and enhancing patient outcomes.

With continued collaboration and dedication, ZAS Corporation strives to contribute to a stronger and more progressive future for hematology care across the country.